摘要
目的观察疏筋解毒汤联合美多芭治疗帕金森病(PD)的临床疗效。方法 32例PD患者随机分为治疗组和对照组,各16例。治疗组给予疏筋解毒汤联合美多芭治疗与单纯美多芭治疗的对照组相比较,疗程1个月。治疗前后通过以UPDRS为主,PDSS为辅进行评分,观察分析两组治疗效果。结果治疗组的临床总有效率(93.75%)明显高于对照组(62.50%),且治疗组改善临床症状优于对照组(P<0.01)。结论疏筋解毒汤联合美多芭治疗PD可明显提高临床疗效。
Objective To observe the clinical effect of Shujinjiedu Prescription and Madopar in the treatment of Parkinson＇s disease.Methods 32 subjects were randomized into two groups： treatment group in which 16 cases were treated with Shujinjiedu Prescription and Madopar,and control group in which 16 cases were only treated with Madopar,with a course of one month.UPDRS was Primarily used to observe and analyze the therapeutic efficacy,PDSS was used preemergencily.Results The total effective of treatment group（93.75 %）were obviously upward control group（62.50 %）,and treatment group was superior to compare with control group in improvement of clinical symptom（P0.01）.Conclusion Combined Shujinjiedu Prescription and Madopar is obviously effective in the treatment of Parkinson＇s disease.
出处
《陕西中医学院学报》
2012年第2期23-25,共3页
Journal of Shaanxi College of Traditional Chinese Medicine
基金
国家自然科学基金项目(30973829)
关键词
帕金森病
疏筋解毒汤
美多芭
Parkinson＇s disease
Shujinjiedu Prescription
Madopar
